+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Neurostimulation Device Market 2019-2027

  • ID: 4908068
  • Report
  • January 2020
  • Region: Global
  • 164 pages
  • Triton Market Research
UP TO OFF
until Sep 30th 2020

FEATURED COMPANIES

  • Cogentix Medical, Inc.
  • Cyberonics Inc.
  • Depuy Synthes Companies
  • Dr. Langer Medical Gmbh
  • Hocoma Ag
  • Medtronic Plc
  • MORE
MARKET OUTLOOK
As per the analysis by the publisher, the global neurostimulation device market is expected to show compelling growth in terms of revenue with a CAGR of 10.23% during the forecasting period 2019-2027.

The rapid growth in the geriatric population, growing demand for MRI scans, rising incidence of neuro diseases, and favorable reimbursement policies are driving the neurostimulation device market. However, factors such as high cost of neuromodulation treatment and the presence of alternative treatment options are obstructing the market growth. Moreover, stringent regulatory approvals and side-effects associated with neurostimulation devices are some of the challenges faced by the market. The market can achieve its predicted growth by leveraging key opportunities such as the high market potential for SCS devices in neurostimulation, technological development, and growing incidence of chronic discomfort.

REGIONAL OUTLOOK
The global neurostimulation device market report covers the regions of North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa.

The Asia-Pacific is the fastest-growing region in the global neurostimulation device market. The market in this region is primarily fueled by the enhancements in healthcare infrastructure, the high pervasiveness of lifestyle diseases such as atherosclerosis, stroke & heart diseases leading to increased surgeries, and the growing confidence of physicians in the use of neurostimulation devices.

In countries like India and China, there is a huge preference given for traditional treatment methods like yoga, physiotherapy, and ayurvedic means. Along with that, a shortage of skilled professionals, a lack of public awareness about neurostimulation devices, and the high cost of devices are expected to restrain the market growth.

COMPETITIVE OUTLOOK
Some outstanding competitors in the neurostimulation device market are Cogentix Medical, Inc., Boston Scientific Corporation, Neuronetics, Inc., DePuy Synthes Companies, Cyberonics, Inc., Nevro Corp., Dr. Langer Medical GmbH, Ectron Limited, St. Jude Medical, Inc. (acquired by Abbott Laboratories), Ekso Bionics Holding Inc., Aleva Neurotherapeutics SA, Medtronic plc, Hocoma AG, Helius Medical Technologies, and The Magstim Company Limited.
St. Jude Medical, Inc. (acquired by Abbott Laboratories) is a global company that manufactures medical devices and develops cost-effective medical technologies.

The company mainly deals with health IT management solutions, including heart failure management, electrophysiology, cardiac rhythm management, structural heart, vascular, and neuromodulation. The company has partnered with various healthcare providers to develop leading technologies and products.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cogentix Medical, Inc.
  • Cyberonics Inc.
  • Depuy Synthes Companies
  • Dr. Langer Medical Gmbh
  • Hocoma Ag
  • Medtronic Plc
  • MORE
1. Global Neurostimulation Device Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter’S Five Forces Model
2.2.1. Threat Of New Entrants
2.2.2. Threat Of Substitutes
2.2.3. Bargaining Power Of Suppliers
2.2.4. Bargaining Power Of Buyers
2.2.5. Threat Of Rivalry
2.3. Value Chain Outlook
2.4. Market Trends
2.5. Market Share Outlook
2.6. Pestle Outlook
2.7. Market Attractiveness Index
2.8. Key Insight
2.9. Market Drivers
2.9.1. Rising Incidence Of Neuro Diseases
2.9.2. Increasing Geriatric Population
2.9.3. Growing Demand For Mri Scans
2.9.4. Favorable Reimbursement Policies
2.10. Market Restraints
2.10.1. High Cost Of Neuromodulation Treatment
2.10.2. Presence Of Alternative Therapy
2.11. Market Opportunities
2.11.1. High Market Potential For Scs Devices In Neurostimulation
2.11.2. Technological Development
2.11.3. Growing Incidence Of Chronic Discomfort
2.12. Market Challenges
2.12.1. Stringent Regulatory Approvals
2.12.2. Side-Effects Associated With Neurostimulation Devices

3. Neurostimulation Device Market Outlook - By System
3.1. Spinal Cord Stimulators (Scs)
3.2. Deep Brain Stimulators (Dbs)
3.3. Sacral Nerve Stimulators (Sns)
3.4. Vagus Nerve Stimulators (Vns)
3.5. Gastric Electric Stimulator
3.6. Other Systems

4. Neurostimulation Device Market Outlook - By Applications
4.1. Pain Management
4.2. Epilepsy
4.3. Essential Tremor
4.4. Urinary And Fecal Incontinence
4.5. Depression
4.6. Dystonia
4.7. Gastroparesis
4.8. Parkinson’S Disease
4.9. Other Applications

5. Neurostimulation Device Market - Regional Outlook
5.1. North America
5.1.1. Market By System
5.1.2. Market By Application
5.1.3. Country Analysis
5.1.3.1. The United States
5.1.3.2. Canada
5.2. Europe
5.2.1. Market By System
5.2.2. Market By Application
5.2.3. Country Analysis
5.2.3.1. The United Kingdom
5.2.3.2. France
5.2.3.3. Germany
5.2.3.4. Spain
5.2.3.5. Italy
5.2.3.6. Russia
5.2.3.7. Rest Of Europe
5.3. Asia-Pacific
5.3.1. Market By System
5.3.2. Market By Application
5.3.3. Country Analysis
5.3.3.1. India
5.3.3.2. China
5.3.3.3. Japan
5.3.3.4. Australia & New Zealand
5.3.3.5. South Korea
5.3.3.6. Asean Countries
5.3.3.7. Rest Of Asia-Pacific
5.4. Latin America
5.4.1. Market By System
5.4.2. Market By Application
5.4.3. Country Analysis
5.4.3.1. Brazil
5.4.3.2. Mexico
5.4.3.3. Rest Of Latin America
5.5. Middle East And Africa
5.5.1. Market By System
5.5.2. Market By Application
5.5.3. Country Analysis
5.5.3.1. Saudi Arabia
5.5.3.2. Turkey
5.5.3.3. The United Arab Emirates
5.5.3.4. South Africa
5.5.3.5. Rest Of Middle East & Africa

6. Company Profiles
6.1. Neuronetics, Inc.
6.2. St. Jude Medical, Inc. (Acquired By Abbott Laboratories)
6.3. Hocoma Ag
6.4. Nevro Corp.
6.5. Cyberonics Inc.
6.6. Cogentix Medical, Inc.
6.7. Depuy Synthes Companies
6.8. Dr. Langer Medical Gmbh
6.9. Medtronic Plc
6.10. The Magstim Company Limited
6.11. Ectron Limited
6.12. Boston Scientific Corporation
6.13. Ekso Bionics Holdings Inc.
6.14. Aleva Neurotherapeutics Sa
6.15. Helius Medical Technologies

7. Research Methodology & Scope
7.1. Research Scope & Deliverables
7.1.1. Objectives Of Study
7.1.2. Scope Of Study
7.2. Sources Of Data
7.2.1. Primary Data Sources
7.2.2. Secondary Data Sources
7.3. Research Methodology
7.3.1. Evaluation Of Proposed Market
7.3.2. Identification Of Data Sources
7.3.3. Assessment Of Market Determinants
7.3.4. Data Collection
7.3.5. Data Validation & Analysis

List Of Tables
Table 1 Global Neurostimulation Device Market By Region 2019-2027 ($ Million)
Table 2 Global Neurostimulation Device Market By System 2019-2027 ($ Million)
Table 3 Global Neurostimulation Device Market By Applications 2019-2027 ($ Million)
Table 4 Global Neurostimulation Device Market By Geography 2019-2027 (In $ Million)
Table 5 North America Neurostimulation Device Market By System 2019-2027 ($ Million)
Table 6 North America Neurostimulation Device Market By Applications 2019-2027 ($ Million)
Table 7 Conditions Treated By Neurostimulation Devices In The United States
Table 8 North America Neurostimulation Device Market By Country 2019-2027 ($ Million)
Table 9 Europe Neurostimulation Device Market By System 2019-2027 ($ Million)
Table 10 Europe Neurostimulation Device Market By Applications 2019-2027 ($ Million)
Table 11 Europe Neurostimulation Device Market By Country 2019-2027 ($ Million)
Table 12 Asia-Pacific Neurostimulation Device Market By System 2019-2027 ($ Million)
Table 13 Asia-Pacific Neurostimulation Device Market By Applications 2019-2027 ($ Million)
Table 14 Asia-Pacific Neurostimulation Device Market By Country 2019-2027 ($ Million)
Table 15 Latin America Neurostimulation Device Market By System 2019-2027 ($ Million)
Table 16 Latin America Neurostimulation Device Market By Applications 2019-2027 ($ Million)
Table 17 Latin America Neurostimulation Device Market By Country 2019-2027 ($ Million)
Table 18 Middle East And Africa Neurostimulation Device Market By System 2019-2027 ($ Million)
Table 19 Middle East And Africa Neurostimulation Device Market By Applications 2019-2027 ($ Million)
Table 20 Middle East And Africa Neurostimulation Device Market By Country 2019-2027 ($ Million)

List Of Figures
Figure 1 Global Neurostimulation Device Market 2019-2027 ($ Million)
Figure 2 Value Chain Outlook
Figure 3 Prevalence Of Mental Health Disorders 2012 And 2020 (Million)
Figure 4 Rising Geriatric Population Across The Globe For Period 2014-2020 (Million)
Figure 5 Neurostimulation Device Company Market Share Outlook 2018 (%)
Figure 6 Global Neurostimulation Device Market By Spinal Cord Stimulators 2019-2027 ($ Million)
Figure 7 Global Neurostimulation Device Market By Deep Brain Stimulators 2019-2027 ($ Million)
Figure 8 Global Neurostimulation Device Market By Sacral Nerve Stimulators 2019-2027 ($ Million)
Figure 9 Global Neurostimulation Device Market By Vagus Nerve Stimulators 2019-2027 ($ Million)
Figure 10 Global Neurostimulation Device Market By Gastric Electric Stimulator 2019-2027 ($ Million)
Figure 11 Global Neurostimulation Device Market By Other System 2019-2027 ($ Million)
Figure 12 Global Neurostimulation Device Market By Pain Management 2019-2027 ($ Million)
Figure 13 Global Neurostimulation Device Market By Epilepsy 2019-2027 ($ Million)
Figure 14 Global Neurostimulation Device Market By Essential Tremor 2019-2027 ($ Million)
Figure 15 Global Neurostimulation Device Market By Urinary And Fecal Incontinence 2019-2027 ($ Million)
Figure 16 Global Neurostimulation Device Market By Depression 2019-2027 ($ Million)
Figure 17 Global Neurostimulation Device Market By Dystonia 2019-2027 ($ Million)
Figure 18 Global Neurostimulation Device Market By Gastroparesis 2019-2027 ($ Million)
Figure 19 Global Neurostimulation Device Market By Parkinson’S Disease 2019-2027 ($ Million)
Figure 20 Global Neurostimulation Device Market By Other Applications 2019-2027 ($ Million)
Figure 21 The United States Neurostimulation Device Market 2019-2027 ($ Million)
Figure 22 Canada Neurostimulation Device Market 2019-2027 ($ Million)
Figure 23 The United Kingdom Neurostimulation Device Market 2019-2027 ($ Million)
Figure 24 France Neurostimulation Device Market 2019-2027 ($ Million)
Figure 25 Germany Neurostimulation Device Market 2019-2027 ($ Million)
Figure 26 Spain Neurostimulation Device Market 2019-2027 ($ Million)
Figure 27 Italy Neurostimulation Device Market 2019-2027 ($ Million)
Figure 28 Russia Neurostimulation Device Market 2019-2027 ($ Million)
Figure 29 Rest Of Europe Neurostimulation Device Market 2019-2027 ($ Million)
Figure 30 India Neurostimulation Device Market 2019-2027 ($ Million)
Figure 31 China Neurostimulation Device Market 2019-2027 ($ Million)
Figure 32 Japan Neurostimulation Device Market 2019-2027 ($ Million)
Figure 33 Australia & New Zealand Neurostimulation Device Market 2019-2027 ($ Million)
Figure 34 South Korea Neurostimulation Device Market 2019-2027 ($ Million)
Figure 35 Asean Countries Neurostimulation Device Market 2019-2027 ($ Million)
Figure 36 Rest Of Asia-Pacific Neurostimulation Device Market 2019-2027 ($ Million)
Figure 37 Brazil Neurostimulation Device Market 2019-2027 ($ Million)
Figure 38 Mexico Neurostimulation Device Market 2019-2027 ($ Million)
Figure 39 Rest Of Latin America Neurostimulation Device Market 2019-2027 ($ Million)
Figure 40 Saudi Arabia Neurostimulation Device Market 2019-2027 ($ Million)
Figure 41 Turkey Neurostimulation Device Market 2019-2027 ($ Million)
Figure 42 The United Arab Emirates Neurostimulation Device Market 2019-2027 ($ Million)
Figure 43 South Africa Neurostimulation Device Market 2019-2027 ($ Million)
Figure 44 Rest Of Middle East & Africa Neurostimulation Device Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
  • Neuronetics, Inc.
  • St. Jude Medical, Inc. (Acquired By Abbott Laboratories)
  • Hocoma Ag
  • Nevro Corp.
  • Cyberonics Inc.
  • Cogentix Medical, Inc.
  • Depuy Synthes Companies
  • Dr. Langer Medical Gmbh
  • Medtronic Plc
  • The Magstim Company Limited
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll